Evidence map›Paper›PMID 39667406›Full record

Observational studyThe journal of knee surgery2025

Prospective Evaluation of Clinical Outcomes of the Subchondroplasty Procedure for Treatment of Symptomatic Bone Marrow Lesions of the Knee.

Steven B Cohen, Christopher Hajnik, Gregory J Loren, Sam Akhavan, Patrick J DeMeo, Douglas J Wyland, Thomas Youm, Laith M Jazrawi, Robert J Daley, Jack Farr and 2 more

Abstract readObservational StudyMulticenter Study
In one paragraph

Observational study in The journal of knee surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Steven B CohenRothman Institute at Thomas Jefferson University Hospital, Philadelphia, Pennsylvania.
Christopher HajnikCORE Orthopaedic Medical Center, Orthopaedic Surgeons, Encinitas, California.
Gregory J LorenCORE Orthopaedic Medical Center, Orthopaedic Surgeons, Encinitas, California.
Sam AkhavanDepartment of Orthopaedic Surgery, Allegheny General Hospital, Pittsburgh, Pennsylvania.
Patrick J DeMeoDepartment of Orthopaedic Surgery, Allegheny General Hospital, Pittsburgh, Pennsylvania.
Douglas J WylandPrisma Health Steadman Hawkins Clinic of the Carolinas, Greenville, South Carolina.
Thomas YoumNYU Hospital for Joint Diseases, New York, New York.
Laith M JazrawiNYU Hospital for Joint Diseases, New York, New York.
Robert J DaleyHinsdale Orthopaedics, A Division of Illinois Bone and Joint Institute, Hinsdale, Illinois.
Jack FarrIndiana University School of Medicine and OrthoIndy Hospital, Indianapolis, Indiana.
Patrick ReischlingZimmer Biomet, Inc. Warsaw, Indiana.
Jennifer E Woodell-MayZimmer Biomet, Inc. Warsaw, Indiana.ORCID 0000-0003-1650-5831

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bone marrow lesions (BMLs) have a strong correlation to patient-reported pain, functional limitations, joint deterioration, and rapid progression to total knee arthroplasty. The Subchondroplasty (SCP) procedure uses AccuFill, a calcium phosphate bone substitute material (BSM), to treat bone defects such as microtrabecular fractures and BML. This observational, prospective, multicenter, cohort study evaluated the effect of the SCP procedure at the 2-year follow-up for 70 patients with knee BML. Under arthroscopic and fluoroscopic guidance, the BML was injected with AccuFill. Patient-reported outcomes, including Visual Analog Scale (VAS) pain, Knee Injury and Osteoarthritis Outcome Score (KOOS), International Knee Documentation Committee (IKDC), and modified Knee Society Score (mKSS) were collected through 24 months postoperatively. Radiographs and magnetic resonance imaging (MRI) were performed at baseline and up to 24 months postoperatively. Patient selection was not limited based on the degree of osteoarthritis (OA) as determined radiologically by the Kellgren-Lawrence (K-L) grade. For a subset of patients, patient-reported outcomes were collected up to 5 years including pain evaluation, patient knee global assessment, and satisfaction with the procedure. Preoperative radiographs indicated moderate to severe OA (K-L grades 2-4) in 65 patients (92.8%). Significant improvements (

Indexed as

Bone Marrow DiseasesBone SubstitutesCalcium PhosphatesKnee JointAdultAgedArthroplasty, Replacement, KneeArthroscopyFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedOsteoarthritis, KneePain MeasurementPatient Reported Outcome MeasuresBone Substitutescalcium phosphateCalcium Phosphates

Identifiers

PMID39667406
PMCPMC12020494

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.